EDGAR Filing Documents for 0001144204-10-013215

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-10-013215

Filing Date

2010-03-12

Accepted

2010-03-12 17:29:49

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		v177135_10k.htm	10-K	2702210
2	GRAPHIC	chart.jpg	GRAPHIC	46740
3		v177135_ex10-66.htm	EX-10.66	31029
4		v177135_ex10-67.htm	EX-10.67	39756
5		v177135_ex10-68.htm	EX-10.68	16108
6		v177135_ex10-69.htm	EX-10.69	137991
7		v177135_ex21.htm	EX-21	11475
8		v177135_ex23-1.htm	EX-23.1	5036
9		v177135_ex31-1.htm	EX-31.1	19120
10		v177135_ex31-2.htm	EX-31.2	16582
11		v177135_ex32-1.htm	EX-32.1	6077
12		v177135_ex32-2.htm	EX-32.2	6693
	Complete submission text file	0001144204-10-013215.txt		3058068

Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103

Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080

HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)